TLSI:NASDAQ, TriSalus Life Sciences, Inc.

Why TLSI stock fell on November 11

TriSalus Life Sciences, Inc. fell 19.3% on Wednesday, November 11, 2026, on 913,400 shares, 3.2 times its average daily volume. Headlines around the move:

Nov 10: TriSalus Life Sciences, Inc. Q3 2026 Earnings Call Summary
Nov 10: TriSalus: 3 Key Takeaways for Long-Term Investors
Nov 10: TriSalus (TLSI) Q3 2026 Earnings Call Transcript

TLSI stock overview

TriSalus Life Sciences, Inc. (TLSI:NASDAQ) closed at $2.43 on November 13, 2026, down 3.57% on the day. The stock trades 69.4% below its 52-week high of $7.95 and 10.5% above its 52-week low of $2.20. Over the past year, it lost 45.8%. TriSalus Life Sciences, Inc. is part of the Finance sector.

Key figures

Price: $2.43
Day change: -3.57%
Volume: 403,858
Average volume: 286,448
Market cap: 149M+
52-week range: $2.20 – $7.95
50-day average: $4.10
200-day average: $4.30

Price action over the past year

In 252 trading sessions since November 13, 2025, TLSI closed higher on 122 days (48%). Its best day was February 20, 2026 (+18.22%) and its worst was May 13, 2026 (-41.45%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

Nov 14, 2026: News catalyst: Guidance (News Catalysts scanner)
Nov 11, 2026: Dropped 19.3% in a single session (Dips & Crashes scanner)

TLSI news

Nov 14, 2026: TriSalus Life Sciences (TLSI) Stock Fair Value Moves Lower After Q3 Miss And Guidance Reset
Nov 10, 2026: TriSalus Life Sciences, Inc. Q3 2026 Earnings Call Summary
Nov 10, 2026: TriSalus: 3 Key Takeaways for Long-Term Investors
Nov 10, 2026: TriSalus (TLSI) Q3 2026 Earnings Call Transcript
Nov 10, 2026: TriSalus Life Sciences Q3 Earnings Call Highlights
Nov 10, 2026: TriSalus Misses Again And Cuts Guidance A Third Time, Overshadowing A Sequential Rebound And Favorable 2027 Reimbursement
Nov 10, 2026: TriSalus Life Sciences Reports 11.3% Q3 Revenue Growth to $12.9 Million, Revises 2026 Guidance
Nov 10, 2026: TriSalus Life Sciences Reports Third Quarter 2026 Results

About TriSalus Life Sciences, Inc.

MedTech Acquisition Corp is a blank check company.

Similar stocks

Find more stocks like TLSI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.